All Articles

New report shows LinkedIn is the only platform with positive B2B ROAS, as the customer journey becomes a complex, seven-month marathon of self-education.

A $12.2M impairment charge pushed Ultralife to a net loss, but rising sales, a soaring backlog, and new efficiencies tell a far more positive story.

As D-Wave prepares for a major physics summit, its unique dual-platform strategy and new gate-model breakthroughs could challenge industry giants.

Lenovo's Hybrid AI moves from pilots to real-world impact, tackling readiness gaps to fuel Hong Kong's ambitious 'AI+' strategy. Here's how.

The alternative beverage market is booming with functional drinks. Discover how distributors like TruLife are the key link between innovation and your shopping cart.

Soluna Holdings is aggressively expanding from Bitcoin to AI, betting its future on turning wasted renewable energy into high-demand computing power.

With its CAR-T therapy achieving franchise profitability and treating 10,000 patients, Legend Biotech eyes overall profit and next-gen cancer treatments.

Progressive Planet's new Planet LCD Cement uses waste materials to replace 50% of Portland cement, promising stronger, cheaper, and greener concrete.

New drilling reveals significant high-grade zones at Freegold’s massive Golden Summit project, boosting confidence ahead of a key feasibility study.

A severe freezing rain event is hitting Ontario, Quebec, and Atlantic Canada, with officials warning of extended power outages and hazardous conditions.

A new report reveals why large dogs face longer shelter stays. Low confidence, cost, and housing barriers are creating a crisis, but solutions are emerging.

The EV maker reported a landmark non-GAAP operating profit in Q4 2025, fueled by record sales across its three brands and aggressive cost-cutting.

Finance veteran Stephen Siderow brings institutional expertise to a burgeoning real estate tech VC, aiming to capitalize on AI-driven disruption.

With a new Chief Growth Officer and major investor backing, Guidelight Health is poised for aggressive expansion in the booming mental health care market.

Censys launches ARC, a research collective formalizing its mission to protect critical infrastructure by mapping the web's most dangerous exposures.

The new partnership aims to replace periodic audits with continuous, AI-driven trust, reshaping the GRC landscape for the modern enterprise.

Promising clinical trial results for Insulet's fully closed-loop system aim to revolutionize daily management for millions with Type 2 diabetes.

The ancient capital charts a bold course for 2026, betting on innovation, new energy, and global trade to become a leading economic engine in Western China.

Tenax Therapeutics achieves a major clinical trial goal, moving its promising drug TNX-103 closer to becoming the first approved therapy for a deadly heart condition.

Microsoft Fabric promises a unified data utopia, but firms face real-world hurdles. DataStrike's new services aim to bridge the gap from promise to production.